Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis

Europace

Volumn 15, Issue 3, 2013, Pages 347-354

  Kron, Jordana ^a   Sauer, William ^b   Schuller, Joseph ^b   Bogun, Frank ^c   Crawford, Thomas ^c   Sarsam, Sinan ^c   Rosenfeld, Lynda ^d   Mitiku, Teferi Y ^d   Cooper, Joshua M ^e   Mehta, Davendra ^f   Greenspon, Arnold J ^g   Ortman, Matthew ^g   Delurgio, David B ^h   Valadri, Ravinder ^h   Narasimhan, Calambur ⁱ   Swapna, Nalla ⁱ   Singh, Jagmeet P ^j   Danik, Stephan ^j   Markowitz, Steven M ^k   Almquist, Adrian K ^l   Krahn, Andrew D ^m   Wolfe, Luke G ^a   Feinstein, Shawn ^a   Ellenbogen, Kenneth A ^a   more..

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d YALE UNIVERSITY   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f MOUNT SINAI HOSPITAL   (United States)

^g THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^h EMORY UNIVERSITY   (United States)

ⁱ CARE HOSPITAL   (India)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

^k WEILL CORNELL MEDICAL CENTER   (United States)

^l MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^m UNIVERSITY OF WESTERN ONTARIO   (Canada)

more..

Author keywords

Cardiac sarcoidosis; Implantable cardiac defibrillator

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DISOPYRAMIDE; DOFETILIDE; FLECAINIDE; PROPAFENONE; QUINIDINE; SOTALOL;

ADULT; AGED; ARTICLE; CARDIAC SARCOIDOSIS; CATHETER ABLATION; ELECTROCARDIOGRAM; FAINTNESS; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL INFORMATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAFETY; SARCOIDOSIS; SHOCK; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; CANADA; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; PRIMARY PREVENTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SARCOIDOSIS; SECONDARY PREVENTION; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VENTRICULAR FIBRILLATION; YOUNG ADULT;

EID: 84874426913     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus316     Document Type: Article

References (18)

1. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: A clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978;58:1204-11.
2. Tavora F, Cresswell N, Li L, Ripple M, Solomon C, Burke A. Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am J Cardiology 2009;104:571-7.
3. Uusimaa P, Ylitalo K, Anttonen O, Kerola T, Virtanen V, PaakköE et al. Ventricular tachyarrhythmia as a primary presentation of sarcoidosis. Europace 2008;10: 760-6.
4. Bajaj AK, Kopelman HA, Echt DS. Cardiac sarcoidosis with sudden death: Treatment with the automatic implantable cardioverter defibrillator. Am Heart J 1988;116:557-60.
5. Hermosilla Cabrerizo T, Rodrigo Trallero G, Sua'rez Alzamora J, Pelegri'n Di'az J, Zabala Lo'pez S, Di'ez Manglano J et al. [Myocardial sarcoidosis treated with implantable defibrillator]. An Med Interna 1991;8:338-40.
6. Paz HL, McCormick DJ, Kutalek SP, Patchefsky A. The automated implantable cardiac defibrillator: Prophylaxis in cardiac sarcoidosis. Chest 1994;106:1603-7.
7. Betensky BP, Tschabrunn CM, Zado ES, Goldberg LR, Marchlinski FE, Garcia FC et al. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm 2012;6:884-91.
8. Schuller JL, Zipse M, Crawford T, Bogun F, Beshai J, Patel A et al. Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J Cardiovasc Electrophysiol 2012 Jul 19. doi: 10.1111/j.1540-8167. 2012.02350.x. [Epub ahead of print].
9. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;51:e1-62.
10. Aizer A, Stern EH, Gomes JA, Teirstein AS, Eckart RE, Mehta D. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J Cardiol 2005;96:276-82.
11. Banba K, Kusano KF, Nakamura K, Morita H, Ogawa A, Ohtsuka F et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm 2007;4:1292-9.
12. Yodogawa K, Seino Y, Ohara T, Takayama H, Katoh T, Mizuno K. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann Noninvasive Electrocardiol 2011;16:140-7.
13. Winters SL, Cohen M, Greenberg S, Stein B, Curwin J, Pe E et al. Sustained ventricular tachycardia associated with sarcoidosis: Assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J Am Coll Cardiol 1991;18: 937-43.
14. Kim JS, Judson MA, Donnino R. Cardiac sarcoidosis. Am Heart J 2009;157:9-21.
15. Birnie DH, Parkash R, Exner DV, Essebag V, Healey JS, Verma A et al. Clinical predictors of Fidelis lead failure: Report from the Canadian Heart Rhythm Society Device Committee. Circulation 2012;125:1217-25.
16. Girerd N, Nonin E, Pinot J, Morel E, Flys C, Scridon A et al. Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age. Arch Cardiovasc Dis 2011;104: 388-95.
17. Schuller JL, Lowery CM, Weinberger HD, Sauer WH. Fluctuation in ventricular sensing leading to underdetection of ventricular fibrillation in a patient with cardiac sarcoidosis. J Interv Card Electrophysiol 2011;30:81-5.
18. Mehta D, Mori N, Goldbarg SH, Lubitz S, Wisnivesky JP, Teirstein A. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: Role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol 2011;4:43-78.